GNH USA

Europe — EMA

Noradrenaline (Norepinephrine) Aguettant (Noradrenaline Tartrate)

GNH USA supplies Noradrenaline (Norepinephrine) Aguettant, a vasopressor for acute hypotension, shock and cardiac arrest. Request a quote for global supply.

Request sourcing

1
Pack/s

What is Noradrenaline Tartrate?

Noradrenaline Tartrate, the active ingredient in Noradrenaline (Norepinephrine) Aguettant, is an adrenergic agonist presented as an injectable solution for intravenous use. It is employed to raise blood pressure in patients with acute hypotension, various forms of shock, and during cardiac arrest in critical care settings.

GNH USA supplies Noradrenaline (Norepinephrine) Aguettant as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, with established cold‑chain logistics and regulatory expertise to meet diverse market requirements.

What is Noradrenaline Tartrate used for?

Noradrenaline (norepinephrine) is an adrenergic vasopressor used to manage conditions characterized by low blood pressure.

- Acute hypotension: restores systemic vascular resistance and improves perfusion pressure. - Cardiogenic shock: supports hemodynamics by increasing cardiac output and arterial pressure. - Cardiac arrest: provides immediate vasoconstriction to facilitate coronary and cerebral perfusion during resuscitation.

What are the side effects of Noradrenaline Tartrate?

Noradrenaline may be associated with a range of adverse reactions, varying from frequent to rare but serious.

Common Side Effects: - Headache: transient headache due to vascular changes. - Tachycardia: increased heart rate. - Arrhythmia: ectopic beats or rhythm disturbances. - Extravasation: local pain and tissue irritation at the infusion site.

Serious or Rare Side Effects: - Severe hypertension: excessive rise in blood pressure. - Myocardial ischemia: reduced coronary perfusion leading to chest pain. - Peripheral ischemia: tissue necrosis from prolonged vasoconstriction. - Cardiac arrest: paradoxical event in susceptible patients.

What precautions apply to Noradrenaline Tartrate?

When using Noradrenaline, careful monitoring and specific safety measures are required.

- Dose titration: adjust infusion rate to achieve target mean arterial pressure. - Cardiovascular monitoring: continuously monitor blood pressure and heart rhythm. - Extravasation risk: avoid infiltration; stop infusion immediately if signs appear. - Use in pregnancy: only if benefit outweighs risk; limited data available. - Drug compatibility: verify compatibility with IV solutions and other medications. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Noradrenaline Tartrate interact with?

Noradrenaline can interact with several drug classes, necessitating vigilance.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis. - Tricyclic antidepressants: additive sympathomimetic effects. - Beta‑blockers: may blunt desired cardiac response. - Vasopressin: excessive vasoconstriction.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance hypotensive episodes after discontinuation. - Calcium channel blockers: may affect vascular tone. - Opioids: may mask signs of hypertension.

Frequently asked questions

What is Noradrenaline (Norepinephrine) Aguettant used for?+
Noradrenaline (Norepinephrine) Aguettant is a vasopressor indicated for the rapid correction of acute hypotension, various forms of shock, and cardiac arrest. It helps raise systemic blood pressure and improve organ perfusion in critical care settings.
How does Noradrenaline work?+
Noradrenaline directly stimulates alpha‑1 adrenergic receptors, causing peripheral vasoconstriction, and beta‑1 receptors in the heart, increasing contractility and heart rate. The combined effect raises systemic vascular resistance and cardiac output, leading to an increase in arterial pressure.
What is the usual dose of Noradrenaline?+
The dosing regimen for Noradrenaline is individualized. The prescribing clinician determines the initial infusion rate and subsequent titration based on the patient’s hemodynamic response and the target mean arterial pressure.
Is Noradrenaline safe in pregnancy or breastfeeding?+
Safety data for Noradrenaline in pregnancy and lactation are limited. It should be used only when the potential benefit to the mother outweighs any potential risk to the fetus or infant, and under close medical supervision.
How do I order Noradrenaline Aguettant from GNH USA?+
Submit an enquiry on the product page at gnh-usa.com with the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.
How does Noradrenaline compare with phenylephrine?+
Both are vasopressors, but phenylephrine is a pure alpha‑1 agonist causing vasoconstriction without significant beta‑1 activity. Noradrenaline also stimulates beta‑1 receptors, providing combined increases in vascular tone and cardiac output, which makes it preferred in many shock states.
What are the storage and handling requirements for Noradrenaline?+
Noradrenaline must be stored at 2‑8 °C, protected from light, and must not be frozen or shaken. Use aseptic technique during preparation, keep the product in its original packaging until use, and follow cold‑chain procedures during transport.
How is Noradrenaline administered?+
Noradrenaline is supplied as a sterile injectable solution for intravenous infusion. It is typically administered via a calibrated infusion pump, with the rate adjusted to achieve the desired blood pressure target while the patient is continuously monitored.
What are the most serious risks associated with Noradrenaline?+
Serious adverse events include severe hypertension, myocardial ischemia, peripheral tissue ischemia, and life‑threatening arrhythmias. If any of these occur, the infusion should be stopped or adjusted immediately and the patient receives urgent medical attention.
Who should not receive Noradrenaline?+
Contraindications include patients with known hypersensitivity to noradrenaline or its excipients and those with uncorrected severe tachyarrhythmias where further increase in heart rate could be hazardous. Caution is also advised in patients with significant peripheral vascular disease.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Noradrenaline Tartrate
Route
Intravenous Use
Manufacturer
Laboratoire Aguettant
Origin
EU

Related products